Drugdiscovery >> Clinical Trials >> News
4993
Views
A combination of conventional and gene therapy for treatment of deadly brain cancer - drugdiscovery.com
A combination of conventional and gene therapy for treatment of deadly brain cancer - drugdiscovery.com


A phase I human clinical trial is expected to start early in 2014. Newly diagnosed glioblastoma multiforme patients, along with standard of care that includes chemo-radiotherapy, will also be treated with allogeneic neural stem cells that carry a novel oncolytic adenovirus that selectively targets GBM and breaks down cancer cells.
Read More >>


Tags: glioblastoma multiforme, clinical trial, gene therapy, stem cells, oncolytic adenovirus, neural stem cells,HB1.F3 NSC - August 12, 2013
Related Articles
16116
Views
Novel brain cancer drug proceeds to the Phase II clinical trial Novel brain cancer drug proceeds to the Phase II clinical trial
The major obstacle for the treatment of malignant brain diseases is the protective blood-brain barrier (BBB), which restricts drug delivery into the central nervous system. To circumvent this issue, a Read More >>

Tags: blood-brain barrier, brain tumor, brain cancer, drug delivery, doxorubicin, G-Technology, liposome

7474
Views
Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial
The data from DUALT 1 trial show that an investigational therapy IDegLira [Tresiba (insulin degludec)/Victoza (liraglutide injection)] achieved statistically significant greater reduction in blood sug Read More >>

Tags: Novo Nordisk, type 2 diabetes, DUALT 1 trial, IDegLira, Tresiba, insulin degludec, Victoza, liraglutide, combination

4439
Views
T-DM1 drug beneficial for patients with advanced HER2 positive breast cancer T-DM1 drug beneficial for patients with advanced HER2 positive breast cancer
The results of the Phase 3 TH3RESA trial show that T-DM1, a conjugated monoclonal antibody in which trastuzumab is combined with a cell-killing drug emtansine (DM1), significantly improves the length Read More >>

Tags: T-DM1, breast cancer, advanced breast cancer, HER2 positive, combination drug, trastuzumab, emtansine, clinical trial

17572
Views
Autologous immune cell therapy tested in liver cancer patients Autologous immune cell therapy tested in liver cancer patients
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of proprietary cell therapies for certain degenerative and malignant diseases, announced positive results from its phase Read More >>

Tags: cancer stem cell, dendritic cell, immunotherapy, liver cancer, phase I trial, liver cancer, hepatocellular carcinoma, HCC, clinical trial, immune cells, therapy, dendritic cells

3728
Views
Reading the Brain: FDA Approves First Scan for Diagnosing ADHD | TIME.com Reading the Brain: FDA Approves First Scan for Diagnosing ADHD | TIME.com
First ever test utilizing brain waves to diagnose ADHD was approved by the FDA. Read More >>

Tags: adhd, approvals, autism, brain, depression

3107
Views
Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer
Merck Serono’s Erbitux (cetuximab) plus FOLFIRI, compared to bevacizumab plus FOLFIRI, has shown a clinically relevant improvement (7.5 month increase in median overall survival) as first-line tr Read More >>

Tags: Erbitux, cetuximab, clinical trail, metastatic, colorectal cancer, Merck, cancer therapy

7068
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

3121
Views
Lilly’s cancer drug unsuccessful in breast cancer trial but shows promise in gastric cancer treatment Lilly’s cancer drug unsuccessful in breast cancer trial but shows promise in gastric cancer treatment
Eli Lilly’s investigational drug ramucirumab, missed its main goal in a late-stage study in patients with advanced breast cancer. The drug performed better in a separate study in patients with advan Read More >>

Tags: Eli Lilly, Lilly, investigational drug, clinical trials, ramucirumab, breast cancer, gastric cancer

3363
Views
Cancer research UK and its phamraceutical partner gain success Cancer research UK and its phamraceutical partner gain success
The clinical trial of Cancer research UK and its partners, such as AstraZeneca and Pfizer proved to be an outstanding success. The promising clinical trials offer a new help for lung cancer treatment. Read More >>

Tags: lung cancer, treatment, cancer research, cancer research UK

4103
Views
GSK has ended the trials of its new lung cancer treatment GSK has ended the trials of its new lung cancer treatment
Phase 3 trial of its MAGE-A3 was reported to be finished by GlaxoSmithKline. They say it is impossible to make sure that the drug is effective against non-small-cell lung cancer. Read More >>

Tags: GSK clinical trial., MAGE-A3, lung cancer, lung cancer drug, lung cancer drug development

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013